Browse > Article
http://dx.doi.org/10.4014/jmb.2004.04016

Suppression of Inflammation, Osteoclastogenesis and Bone Loss by PZRAS Extract  

Li, Liang (Department of Dental Pharmacology, School of Dentistry, Jeonbuk National University)
Park, Young-Ran (Department of Dental Pharmacology, School of Dentistry, Jeonbuk National University)
Shrestha, Saroj Kumar (Department of Dental Pharmacology, School of Dentistry, Jeonbuk National University)
Cho, Hyoung-Kwon (Hanpoong Pharm and Foods Co., Ltd.)
Soh, Yunjo (Department of Dental Pharmacology, School of Dentistry, Jeonbuk National University)
Publication Information
Journal of Microbiology and Biotechnology / v.30, no.10, 2020 , pp. 1543-1551 More about this Journal
Abstract
Panax ginseng has a wide range of activities including a neuroprotective effect, skin protective effects, enhanced DNA repairing, anti-diabetic activity, and protective effects against vascular inflammation. In the present study, we sought to discover the inhibitory effects of a mixture of natural products containing Panax ginseng, Ziziphus jujube, Rubi fructus, Artemisiae asiaticae and Scutellaria baicalensis (PZRAS) on osteoclastogenesis and bone remodeling, as neither the effects of a mixture containing Panax ginseng extract, nor its molecular mechanism on bone inflammation, have been clarified yet. PZRAS upregulated the levels of catalase (CAT), superoxide dismutase (SOD), glutathione reductase (GSH-R) and glutathione peroxidase (GSH-Px) and reduced malondialdehyde (MDA) in LPS-treated RAW264.7 cells. Moreover, treatment with PZRAS decreased the production of IL-1β and TNF-α. PZRAS also inhibited osteoclast differentiation through inhibiting osteoclastspecific genes like MMP-2, 9, cathepsin K, and TRAP in RANKL-treated RAW264.7 cells. Additionally, PZRAS has inhibitory functions on the RANKL-stimulated activation of ERK and JNK, which lead to a decrease in the expression of NFATc1 and c-Fos. In an in vivo study, bone resorption induced by LPS was recovered by treatment with PZRAS in bone volume per tissue volume (BV/TV) compared to control. Furthermore, the ratio of eroded bone surface of femurs was significantly increased in LPS-treated mice compared to vehicle group, but this ratio was significantly reversed in PZRAS-treated mice. These results suggest that PZRAS could prevent or treat disorders with abnormal bone loss.
Keywords
PZRAS; antioxidant; anti-inflammatory; osteoclastogenesis; bone loss;
Citations & Related Records
Times Cited By KSCI : 3  (Citation Analysis)
연도 인용수 순위
1 He JM, Chen SC, Li RP, Yuan LX, Bao JM, Guo ML. 2015. Suppression of nuclear factor-kappa B and mitogen-activated protein kinase signalling pathways by goshonoside-F5 extracted from Rubi Fructus. Int. Immunopharmacol. 24: 182-190.   DOI
2 Diaz P, Jeong SC, Lee S, Khoo C, Koyyalamudi SR. 2012. Antioxidant and anti-inflammatory activities of selected medicinal plants and fungi containing phenolic and flavonoid compounds. Chin. Med. 7: 26.   DOI
3 Wang S, Li J, Sun J, Zeng KW, Cui JR, Jiang Y, et al. 2013. NO inhibitory guaianolide-derived terpenoids from Artemisia argyi. Fitoterapia 85: 169-175.   DOI
4 Wong RW, Rabie AB. 2006. Traditional Chinese medicines and bone formation-a review. J. Oral Maxillofac. Surg. 64: 828-837.   DOI
5 Huet O, Petit JM, Ratinaud MH, Julien R. 1992. NADH-dependent dehydrogenase activity estimation by flow cytometric analysis of 3-(4,5-dimethylthiazolyl-2-yl)-2,5-diphenyltetrazolium bromide (MTT) reduction. Cytometry 13: 532-539.   DOI
6 Prasad K, Mantha SV, Muir AD, Westcott ND. 2000. Protective effect of secoisolariciresinol diglucoside against streptozotocininduced diabetes and its mechanism. Mol. Cell Biochem. 206: 141-149.   DOI
7 Aebi H. Catalase in vitro. 1984. Methods Enzymol. 105: 121-126.   DOI
8 Choi HJ, Eun JS, Park YR, Kim DK, Li R, Moon WS, et al. 2008. Ikarisoside A inhibits inducible nitric oxide synthase in lipopolysaccharide-stimulated RAW 264.7 cells via p38 kinase and nuclear factor-kappaB signaling pathways. Eur. J. Pharmacol. 601: 171-178.   DOI
9 Choi HJ, Park YR, Nepal M, Choi BY, Cho NP, Choi SH, et al. 2010. Inhibition of osteoclastogenic differentiation by Ikarisoside A in RAW 264.7 cells via JNK and NF-kappaB signaling pathways. Eur. J. Pharmacol. 636: 28-35.   DOI
10 Nepal M, Choi HJ, Choi BY, Yang MS, Chae JI, Li L, et al. 2013. Hispidulin attenuates bone resorption and osteoclastogenesis via the RANKL-induced NF-kappaB and NFATc1 pathways. Eur. J. Pharmacol. 715: 96-104.   DOI
11 Luo A, Ge Z, Fan Y, Luo A, Chun Z, He X. 2011. In vitro and in vivo antioxidant activity of a water-soluble polysaccharide from Dendrobium denneanum. Molecules 16: 1579-1592.   DOI
12 Arango Duque G, Descoteaux A. 2014. Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 5: 491
13 Wojdasiewicz P, Poniatowski LA, Szukiewicz D. 2014. The role of inflammatory and anti-inflammatory cytokines in the pathogenesis of osteoarthritis. Mediators Inflamm. 2014: 561459.   DOI
14 Sundaram K, Nishimura R, Senn J, Youssef RF, London SD, Reddy SV. 2007. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation. Exp. Cell Res. 313: 168-178.   DOI
15 Lee KH, Seo IC, Choi MH, Jeong DW. 2018. Roles of mitogen-activated protein kinases in osteoclast biology. Int. J. Mol. Sci. 19: 3004-3024.   DOI
16 Raphael H, Eric J, Rajaram G, Kim CM. 2019. Bone morphogenetic proteins: Their role in regulating osteoclast differentiation. Bone Rep. 10: 100207-100216.   DOI
17 Suda T, Nakamura I, Jimi E, Takahashi N. 1997. Regulation of osteoclast function. J. Bone Miner. Res. 12: 869-79.42.   DOI
18 Wong BR, Josien R, Lee SY, Vologodskaia M, Steinman RM, Choi Y. 1998. The TRAF family of signal transducers mediates NF-${\kappa}B$ activation by the TRANCE receptor. J. Biol. Chem. 273: 28355-28359.   DOI
19 Park JY, Cho HY, Kim JK, Noh KH, Yang JR, Ahn JM, et al. 2005. Chlorella dichloromethane extract ameliorates NO production and iNOS expression through the down-regulation of NF kappa B activity mediated by suppressed oxidative stress in RAW 264.7 macrophages. Clin. Chim. Acta 351: 185-196.   DOI
20 Sheeba MS, Asha VV. 2009. Cardiospermum halicacabum ethanol extract inhibits LPS induced COX-2, TNF-alpha and iNOS expression, which is mediated by NF-kappa B regulation, in AW264.7 cells. J. Ethnopharmacol. 124: 39-44.   DOI
21 Soufli I, Toumi R, Rafa H, Touil-Boukoffa C. 2016. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J. Gastrointest. Pharmacol. Ther. 6: 353-360.
22 Song SB, Tung NH, Quang TH, Ngan NT, Kim KE, Kim YH. 2012. Inhibition of TNF-alpha-mediated NF-kappaB transcriptional activity in HepG2 cells by dammarane-type sponins from Panax ginseng leaves. J. Ginseng Res. 36: 146-152.   DOI
23 Balli U, Cetinkaya BO, Keles GC, Keles ZP, Guler S, Sogut MU, et al. 2016. Assessment of MMP-1, MMP-8 and TIMP-2 in experimental periodontitis treated with kaempferol. J. Periodontal Implant Sci. 46: 84-95.   DOI
24 Rejnmark L, Mosekilde L. 2011. New and emerging antiresorptive treatments in osteoporosis. Curr. Drug Saf. 6: 75-88.   DOI
25 Ralston SH, de Crombrugghe B. 2006. Genetic regulation of bone mass and susceptibility to osteoporosis. Genes Dev. 20: 2492-2506.   DOI
26 McGreevy C, Williams D. 2011. Safety of drugs used in the treatment of osteoporosis. Ther. Adv. Drug Saf. 2: 159-172.   DOI
27 O'Regan RM, Gradishar WJ. 2001. Selective estrogen-receptor modulators in 2001. Oncology (Williston Park, NY) 15: 1177-1185.
28 Khosla S, Westendorf JJ, Oursler MJ. 2008. Building bone to reverse osteoporosis and repair fractures. J. Clin. Invest. 118: 421-428.   DOI
29 Jia M, Nie Y, Cao DP, Xue YY, Wang JS, Zhao L, et al. 2012. Potential antiosteoporotic agents from plants: a comprehensive review. Evid. Based Complement. Alternat. Med. 2012: 364604.
30 Jung HW, Seo UK, Kim JH, Leem KH, Park YK. 2009. Flower extract of Panax notoginseng attenuates lipopolysaccharide-induced inflammatory response via blocking of NF-kappaB signaling pathway in murine macrophages. J. Ethnopharmacol. 122: 313-319.   DOI
31 Adegbola P, Aderibigbe I, Hammed W, Omotayo T. 2017. Antioxidant and anti-inflammatory medicinal plants have potential role in the treatment of cardiovascular disease: a review. Am. J. Cardiovasc. Dis. 7: 19-32.
32 Zhang XY, Tan YL, Cao LY, Wu GY, Xu Q, Shen Y, et al. 2005. Antioxidant enzymes and lipid peroxidation in different forms of schizophrenia treated with typical and atypical antipsychotics. Schizophr. Res. 81: 291-300.   DOI
33 Chen L, Deng H, Cui H, Fang J, Zuo Z, Deng J, et al. 2018. Inflammatory responses and inflammation-associated diseases in organs. Oncotarget 9: 7204-7218.   DOI
34 Kang HS, Lee JY, Kim CJ. 2008. Anti-inflammatory activity of arctigenin from Forsythiae Fructus. J. Ethnopharmacol. 116: 305-312.   DOI
35 Cui XY, Kim JH, Zhao X, Chen BQ, Lee BC, Pyo HB, et al. 2006. Antioxidative and acute anti-inflammatory effects of Campsis grandiflora flower. J. Ethnopharmacol. 103: 223-228.   DOI
36 Sontakke AN, Tare RS. 2002. A duality in the roles of reactive oxygen species with respect to bone metabolism. Clin. Chim. Acta 318: 145-148.   DOI
37 Nishihara T, Koseki T. 2000. Microbial etiology of periodontitis. Periodontol. 2000 36: 14-26.   DOI
38 Feng Z, Weinberg A. 2006. Role of bacteria in health and disease of periodontal tissues. Periodontol 2000 40: 50-76.   DOI
39 Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92: 827-839.   DOI
40 Guan SM, Shu L, Fu SM, Liu B, Xu XL, Wu JZ. 2009. Prevotella intermedia upregulates MMP-1 and MMP-8 expression in human periodontal ligament cells. FEMS Microbiol. Lett. 299: 214-222.   DOI
41 Sorsa T, Tjaderhane L, Konttinen YT, Lauhio A, Salo T, Lee HM, et al. 2006. Matrix metalloproteinases: contribution to pathogenesis, diagnosis and treatment of periodontal inflammation. Ann. Med. 38: 306-321.   DOI
42 Zhang G, Liu A, Zhou Y, San X, Jin T, Jin Y. 2008. Panax ginseng ginsenoside-Rg2 protects memory impairment via anti-apoptosis in a rat model with vascular dementia. J. Ethnopharmacol. 115: 441-448.   DOI
43 Islam S, Hassan F, Tumurkhuu G, Dagvadorj J, Koide N, Naiki Y, et al. 2007. Bacterial lipopolysaccharide induces osteoclast formation in RAW 264.7 macrophage cells. Biochem Biophys. Res. Commun. 360: 346-351.   DOI
44 Smith BJ, Lerner MR, Bu SY, Lucas EA, Hanas JS, Lightfoot SA, et al. 2006. Systemic bone loss and induction of coronary vessel disease in a rat model of chronic inflammation. Bone 38: 378-386.   DOI
45 Itoh K, Udagawa N, Kobayashi K, Suda K, Li X, Takami M, et al. 2003. Lipopolysaccharide promotes the survival of osteoclasts via Toll-like receptor 4, but cytokine production of osteoclasts in response to lipopolysaccharide is different from that of macrophages. J. Immunol. 170: 3688-3695.   DOI
46 Cho YS, Kim CH, Ha TS, Lee SJ, Ahn HY. 2013. Ginsenoside rg2 inhibits lipopolysaccharide-induced adhesion molecule expression in human umbilical vein endothelial cell. Korean J. Physiol. Pharmacol. 17: 133-137.   DOI
47 Zhang H, Jiang L, Ye S, Ye Y, Ren F. 2010. Systematic evaluation of antioxidant capacities of the ethanolic extract of different tissues of jujube (Ziziphus jujuba Mill.) from China. Food Chem. Toxicol. 48: 1461-1465.   DOI